Global Imatinib Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Imatinib Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Imatinib Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Imatinib Drug by Country/Region, 2017, 2022 & 2028

2.2 Imatinib Drug Segment by Type

2.2.1 Tablets

2.2.2 Capsules

2.3 Imatinib Drug Sales by Type

2.3.1 Global Imatinib Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Imatinib Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Imatinib Drug Sale Price by Type (2017-2022)

2.4 Imatinib Drug Segment by Application

2.4.1 Chronic Myelogenous Leukemia

2.4.2 Gastrointestinal Stromal Tumors

2.4.3 Others

2.5 Imatinib Drug Sales by Application

2.5.1 Global Imatinib Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Imatinib Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Imatinib Drug Sale Price by Application (2017-2022)

3 Global Imatinib Drug by Company

3.1 Global Imatinib Drug Breakdown Data by Company

3.1.1 Global Imatinib Drug Annual Sales by Company (2020-2022)

3.1.2 Global Imatinib Drug Sales Market Share by Company (2020-2022)

3.2 Global Imatinib Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Imatinib Drug Revenue by Company (2020-2022)

3.2.2 Global Imatinib Drug Revenue Market Share by Company (2020-2022)

3.3 Global Imatinib Drug Sale Price by Company

3.4 Key Manufacturers Imatinib Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Imatinib Drug Product Location Distribution

3.4.2 Players Imatinib Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Imatinib Drug by Geographic Region

4.1 World Historic Imatinib Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Imatinib Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Imatinib Drug Annual Revenue by Geographic Region

4.2 World Historic Imatinib Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Imatinib Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Imatinib Drug Annual Revenue by Country/Region

4.3 Americas Imatinib Drug Sales Growth

4.4 APAC Imatinib Drug Sales Growth

4.5 Europe Imatinib Drug Sales Growth

4.6 Middle East & Africa Imatinib Drug Sales Growth

5 Americas

5.1 Americas Imatinib Drug Sales by Country

5.1.1 Americas Imatinib Drug Sales by Country (2017-2022)

5.1.2 Americas Imatinib Drug Revenue by Country (2017-2022)

5.2 Americas Imatinib Drug Sales by Type

5.3 Americas Imatinib Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Imatinib Drug Sales by Region

6.1.1 APAC Imatinib Drug Sales by Region (2017-2022)

6.1.2 APAC Imatinib Drug Revenue by Region (2017-2022)

6.2 APAC Imatinib Drug Sales by Type

6.3 APAC Imatinib Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Imatinib Drug by Country

7.1.1 Europe Imatinib Drug Sales by Country (2017-2022)

7.1.2 Europe Imatinib Drug Revenue by Country (2017-2022)

7.2 Europe Imatinib Drug Sales by Type

7.3 Europe Imatinib Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Imatinib Drug by Country

8.1.1 Middle East & Africa Imatinib Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Imatinib Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Imatinib Drug Sales by Type

8.3 Middle East & Africa Imatinib Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Imatinib Drug

10.3 Manufacturing Process Analysis of Imatinib Drug

10.4 Industry Chain Structure of Imatinib Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Imatinib Drug Distributors

11.3 Imatinib Drug Customer

12 World Forecast Review for Imatinib Drug by Geographic Region

12.1 Global Imatinib Drug Market Size Forecast by Region

12.1.1 Global Imatinib Drug Forecast by Region (2023-2028)

12.1.2 Global Imatinib Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Imatinib Drug Forecast by Type

12.7 Global Imatinib Drug Forecast by Application

13 Key Players Analysis

13.1 Novartis

13.1.1 Novartis Company Information

13.1.2 Novartis Imatinib Drug Product Offered

13.1.3 Novartis Imatinib Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis Main Business Overview

13.1.5 Novartis Latest Developments

13.2 Glenmark Pharmaceuticals Ltd.

13.2.1 Glenmark Pharmaceuticals Ltd. Company Information

13.2.2 Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Offered

13.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Glenmark Pharmaceuticals Ltd. Main Business Overview

13.2.5 Glenmark Pharmaceuticals Ltd. Latest Developments

13.3 Sun Pharmaceuticals

13.3.1 Sun Pharmaceuticals Company Information

13.3.2 Sun Pharmaceuticals Imatinib Drug Product Offered

13.3.3 Sun Pharmaceuticals Imatinib Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sun Pharmaceuticals Main Business Overview

13.3.5 Sun Pharmaceuticals Latest Developments

13.4 Actavis Generics

13.4.1 Actavis Generics Company Information

13.4.2 Actavis Generics Imatinib Drug Product Offered

13.4.3 Actavis Generics Imatinib Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Actavis Generics Main Business Overview

13.4.5 Actavis Generics Latest Developments

13.5 Dr. Reddy's Laboratories

13.5.1 Dr. Reddy's Laboratories Company Information

13.5.2 Dr. Reddy's Laboratories Imatinib Drug Product Offered

13.5.3 Dr. Reddy's Laboratories Imatinib Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Dr. Reddy's Laboratories Main Business Overview

13.5.5 Dr. Reddy's Laboratories Latest Developments

13.6 Teva Pharmaceutical Industries Ltd.

13.6.1 Teva Pharmaceutical Industries Ltd. Company Information

13.6.2 Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Offered

13.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Teva Pharmaceutical Industries Ltd. Main Business Overview

13.6.5 Teva Pharmaceutical Industries Ltd. Latest Developments

13.7 Sanofi S.A.

13.7.1 Sanofi S.A. Company Information

13.7.2 Sanofi S.A. Imatinib Drug Product Offered

13.7.3 Sanofi S.A. Imatinib Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sanofi S.A. Main Business Overview

13.7.5 Sanofi S.A. Latest Developments

13.8 Cipla Inc.

13.8.1 Cipla Inc. Company Information

13.8.2 Cipla Inc. Imatinib Drug Product Offered

13.8.3 Cipla Inc. Imatinib Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Cipla Inc. Main Business Overview

13.8.5 Cipla Inc. Latest Developments

13.9 Apotex Inc.

13.9.1 Apotex Inc. Company Information

13.9.2 Apotex Inc. Imatinib Drug Product Offered

13.9.3 Apotex Inc. Imatinib Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Apotex Inc. Main Business Overview

13.9.5 Apotex Inc. Latest Developments

13.10 Mylan Pharms Inc.

13.10.1 Mylan Pharms Inc. Company Information

13.10.2 Mylan Pharms Inc. Imatinib Drug Product Offered

13.10.3 Mylan Pharms Inc. Imatinib Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Mylan Pharms Inc. Main Business Overview

13.10.5 Mylan Pharms Inc. Latest Developments

14 Research Findings and Conclusion

Table 1. Imatinib Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Imatinib Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Tablets

Table 4. Major Players of Capsules

Table 5. Global Imatinib Drug Sales by Type (2017-2022) & (K Units)

Table 6. Global Imatinib Drug Sales Market Share by Type (2017-2022)

Table 7. Global Imatinib Drug Revenue by Type (2017-2022) & ($ million)

Table 8. Global Imatinib Drug Revenue Market Share by Type (2017-2022)

Table 9. Global Imatinib Drug Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Imatinib Drug Sales by Application (2017-2022) & (K Units)

Table 11. Global Imatinib Drug Sales Market Share by Application (2017-2022)

Table 12. Global Imatinib Drug Revenue by Application (2017-2022)

Table 13. Global Imatinib Drug Revenue Market Share by Application (2017-2022)

Table 14. Global Imatinib Drug Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Imatinib Drug Sales by Company (2020-2022) & (K Units)

Table 16. Global Imatinib Drug Sales Market Share by Company (2020-2022)

Table 17. Global Imatinib Drug Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Imatinib Drug Revenue Market Share by Company (2020-2022)

Table 19. Global Imatinib Drug Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Imatinib Drug Producing Area Distribution and Sales Area

Table 21. Players Imatinib Drug Products Offered

Table 22. Imatinib Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Imatinib Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Imatinib Drug Sales Market Share Geographic Region (2017-2022)

Table 27. Global Imatinib Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Imatinib Drug Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Imatinib Drug Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Imatinib Drug Sales Market Share by Country/Region (2017-2022)

Table 31. Global Imatinib Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Imatinib Drug Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Imatinib Drug Sales by Country (2017-2022) & (K Units)

Table 34. Americas Imatinib Drug Sales Market Share by Country (2017-2022)

Table 35. Americas Imatinib Drug Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Imatinib Drug Revenue Market Share by Country (2017-2022)

Table 37. Americas Imatinib Drug Sales by Type (2017-2022) & (K Units)

Table 38. Americas Imatinib Drug Sales Market Share by Type (2017-2022)

Table 39. Americas Imatinib Drug Sales by Application (2017-2022) & (K Units)

Table 40. Americas Imatinib Drug Sales Market Share by Application (2017-2022)

Table 41. APAC Imatinib Drug Sales by Region (2017-2022) & (K Units)

Table 42. APAC Imatinib Drug Sales Market Share by Region (2017-2022)

Table 43. APAC Imatinib Drug Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Imatinib Drug Revenue Market Share by Region (2017-2022)

Table 45. APAC Imatinib Drug Sales by Type (2017-2022) & (K Units)

Table 46. APAC Imatinib Drug Sales Market Share by Type (2017-2022)

Table 47. APAC Imatinib Drug Sales by Application (2017-2022) & (K Units)

Table 48. APAC Imatinib Drug Sales Market Share by Application (2017-2022)

Table 49. Europe Imatinib Drug Sales by Country (2017-2022) & (K Units)

Table 50. Europe Imatinib Drug Sales Market Share by Country (2017-2022)

Table 51. Europe Imatinib Drug Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Imatinib Drug Revenue Market Share by Country (2017-2022)

Table 53. Europe Imatinib Drug Sales by Type (2017-2022) & (K Units)

Table 54. Europe Imatinib Drug Sales Market Share by Type (2017-2022)

Table 55. Europe Imatinib Drug Sales by Application (2017-2022) & (K Units)

Table 56. Europe Imatinib Drug Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Imatinib Drug Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Imatinib Drug Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Imatinib Drug Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Imatinib Drug Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Imatinib Drug Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Imatinib Drug Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Imatinib Drug Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Imatinib Drug Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Imatinib Drug

Table 66. Key Market Challenges & Risks of Imatinib Drug

Table 67. Key Industry Trends of Imatinib Drug

Table 68. Imatinib Drug Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Imatinib Drug Distributors List

Table 71. Imatinib Drug Customer List

Table 72. Global Imatinib Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Imatinib Drug Sales Market Forecast by Region

Table 74. Global Imatinib Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Imatinib Drug Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Imatinib Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Imatinib Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Imatinib Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Imatinib Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Imatinib Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Imatinib Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Imatinib Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Imatinib Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Imatinib Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Imatinib Drug Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Imatinib Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Imatinib Drug Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Imatinib Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Imatinib Drug Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Imatinib Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Imatinib Drug Revenue Market Share Forecast by Application (2023-2028)

Table 92. Novartis Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors

Table 93. Novartis Imatinib Drug Product Offered

Table 94. Novartis Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Novartis Main Business

Table 96. Novartis Latest Developments

Table 97. Glenmark Pharmaceuticals Ltd. Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors

Table 98. Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Offered

Table 99. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Glenmark Pharmaceuticals Ltd. Main Business

Table 101. Glenmark Pharmaceuticals Ltd. Latest Developments

Table 102. Sun Pharmaceuticals Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors

Table 103. Sun Pharmaceuticals Imatinib Drug Product Offered

Table 104. Sun Pharmaceuticals Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Sun Pharmaceuticals Main Business

Table 106. Sun Pharmaceuticals Latest Developments

Table 107. Actavis Generics Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors

Table 108. Actavis Generics Imatinib Drug Product Offered

Table 109. Actavis Generics Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Actavis Generics Main Business

Table 111. Actavis Generics Latest Developments

Table 112. Dr. Reddy's Laboratories Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors

Table 113. Dr. Reddy's Laboratories Imatinib Drug Product Offered

Table 114. Dr. Reddy's Laboratories Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Dr. Reddy's Laboratories Main Business

Table 116. Dr. Reddy's Laboratories Latest Developments

Table 117. Teva Pharmaceutical Industries Ltd. Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors

Table 118. Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Offered

Table 119. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Teva Pharmaceutical Industries Ltd. Main Business

Table 121. Teva Pharmaceutical Industries Ltd. Latest Developments

Table 122. Sanofi S.A. Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors

Table 123. Sanofi S.A. Imatinib Drug Product Offered

Table 124. Sanofi S.A. Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Sanofi S.A. Main Business

Table 126. Sanofi S.A. Latest Developments

Table 127. Cipla Inc. Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors

Table 128. Cipla Inc. Imatinib Drug Product Offered

Table 129. Cipla Inc. Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Cipla Inc. Main Business

Table 131. Cipla Inc. Latest Developments

Table 132. Apotex Inc. Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors

Table 133. Apotex Inc. Imatinib Drug Product Offered

Table 134. Apotex Inc. Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Apotex Inc. Main Business

Table 136. Apotex Inc. Latest Developments

Table 137. Mylan Pharms Inc. Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors

Table 138. Mylan Pharms Inc. Imatinib Drug Product Offered

Table 139. Mylan Pharms Inc. Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Mylan Pharms Inc. Main Business

Table 141. Mylan Pharms Inc. Latest Developments

List of Figures

Figure 1. Picture of Imatinib Drug

Figure 2. Imatinib Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Imatinib Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Imatinib Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Imatinib Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Tablets

Figure 10. Product Picture of Capsules

Figure 11. Global Imatinib Drug Sales Market Share by Type in 2021

Figure 12. Global Imatinib Drug Revenue Market Share by Type (2017-2022)

Figure 13. Imatinib Drug Consumed in Chronic Myelogenous Leukemia

Figure 14. Global Imatinib Drug Market: Chronic Myelogenous Leukemia (2017-2022) & (K Units)

Figure 15. Imatinib Drug Consumed in Gastrointestinal Stromal Tumors

Figure 16. Global Imatinib Drug Market: Gastrointestinal Stromal Tumors (2017-2022) & (K Units)

Figure 17. Imatinib Drug Consumed in Others

Figure 18. Global Imatinib Drug Market: Others (2017-2022) & (K Units)

Figure 19. Global Imatinib Drug Sales Market Share by Application (2017-2022)

Figure 20. Global Imatinib Drug Revenue Market Share by Application in 2021

Figure 21. Imatinib Drug Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Imatinib Drug Revenue Market Share by Company in 2021

Figure 23. Global Imatinib Drug Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Imatinib Drug Revenue Market Share by Geographic Region in 2021

Figure 25. Global Imatinib Drug Sales Market Share by Region (2017-2022)

Figure 26. Global Imatinib Drug Revenue Market Share by Country/Region in 2021

Figure 27. Americas Imatinib Drug Sales 2017-2022 (K Units)

Figure 28. Americas Imatinib Drug Revenue 2017-2022 ($ Millions)

Figure 29. APAC Imatinib Drug Sales 2017-2022 (K Units)

Figure 30. APAC Imatinib Drug Revenue 2017-2022 ($ Millions)

Figure 31. Europe Imatinib Drug Sales 2017-2022 (K Units)

Figure 32. Europe Imatinib Drug Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Imatinib Drug Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Imatinib Drug Revenue 2017-2022 ($ Millions)

Figure 35. Americas Imatinib Drug Sales Market Share by Country in 2021

Figure 36. Americas Imatinib Drug Revenue Market Share by Country in 2021

Figure 37. United States Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Imatinib Drug Sales Market Share by Region in 2021

Figure 42. APAC Imatinib Drug Revenue Market Share by Regions in 2021

Figure 43. China Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Imatinib Drug Sales Market Share by Country in 2021

Figure 50. Europe Imatinib Drug Revenue Market Share by Country in 2021

Figure 51. Germany Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Imatinib Drug Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Imatinib Drug Revenue Market Share by Country in 2021

Figure 58. Egypt Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Imatinib Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Imatinib Drug in 2021

Figure 64. Manufacturing Process Analysis of Imatinib Drug

Figure 65. Industry Chain Structure of Imatinib Drug

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles